Standpoint Research Upgrades Crocs (CROX) to Buy; Use Dip As Entry Point
Get Alerts CROX Hot Sheet
Price: $122.44 --0%
Rating Summary:
20 Buy, 12 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 19 | New: 23
Rating Summary:
20 Buy, 12 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 19 | New: 23
Join SI Premium – FREE
Standpoint Research upgraded Crocs (NASDAQ: CROX) from Hold to Buy with a price target of $25.00.
Analyst, Ronnie Moas, said, "This is our sixth time in this name in less than three years … we are 5-for-5 so far; see table below. For the record, I usually go into this after an earnings disappointment and sell on a beat...This is a name that doesn’t need to be over-analyzed...Our long term outlook is unchanged … $1.75 in EPS potential looking out to 2013-2014 and we would attach a 14X multiple to that."
For an analyst ratings summary and ratings history on Crocs click here. For more ratings news on Crocs click here.
Shares of Crocs closed at $22.04 yesterday.
Analyst, Ronnie Moas, said, "This is our sixth time in this name in less than three years … we are 5-for-5 so far; see table below. For the record, I usually go into this after an earnings disappointment and sell on a beat...This is a name that doesn’t need to be over-analyzed...Our long term outlook is unchanged … $1.75 in EPS potential looking out to 2013-2014 and we would attach a 14X multiple to that."
For an analyst ratings summary and ratings history on Crocs click here. For more ratings news on Crocs click here.
Shares of Crocs closed at $22.04 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman: 'Our top picks include XYZ, KLAR, AFRM, and CHYM'
- Mizuho Upgrades Five Below (FIVE) to Outperform, 'we believe the pendulum has swung too far on valuation'
- HSBC Starts Syrma SGS Technology (SYRMA:IN) at Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Standpoint Research, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share